Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
Ainos (NASDAQ:AIMD), a company specializing in AI-powered scent detection, has announced its participation in an upcoming fireside chat with Water Tower Research on August 20, 2025, at 11:00 a.m. ET.
During the chat, the company will discuss its AI Nose technology, recent strategic partnerships, and deployment progress. Management will also address market opportunities, upcoming milestones for 2025-2026, and position Ainos as a core technology company. The event will be available for replay on the company's investor relations website.
Ainos (NASDAQ:AIMD), specializzata nella rilevazione degli odori tramite intelligenza artificiale, ha annunciato la sua partecipazione a un incontro informale con Water Tower Research il 20 agosto 2025 alle 11:00 ET (ora orientale).
Durante l'incontro la società illustrerà la sua tecnologia AI Nose, le recenti partnership strategiche e i progressi nelle implementazioni. Il management affronterà inoltre le opportunità di mercato, i traguardi previsti per il 2025-2026 e il posizionamento di Ainos come società tecnologica di riferimento. L'evento sarà disponibile in replay sul sito web delle relazioni con gli investitori della società.
Ainos (NASDAQ:AIMD), especializada en detección de aromas mediante IA, ha anunciado su participación en una conversación con Water Tower Research el 20 de agosto de 2025 a las 11:00 a.m. ET (hora del Este).
Durante la charla la compañía expondrá su tecnología AI Nose, las recientes alianzas estratégicas y los avances en despliegues. La dirección también abordará las oportunidades de mercado, los hitos previstos para 2025-2026 y el posicionamiento de Ainos como empresa tecnológica clave. El evento estará disponible en reproducción en la web de relaciones con inversores de la compañía.
Ainos (NASDAQ:AIMD)는 AI 기반 향기 감지 전문 기업으로, 2025년 8월 20일 오전 11시(미국 동부시간, ET)에 Water Tower Research와의 파이어사이드 토크에 참여한다고 발표했습니다.
이번 대담에서 회사는 AI Nose 기술, 최근 전략적 파트너십 및 배치(도입) 진행 상황을 설명할 예정입니다. 경영진은 또한 시장 기회, 2025~2026년의 예정된 주요 마일스톤, Ainos를 핵심 기술 기업으로 자리매김하기 위한 계획 등에 대해 다룰 것입니다. 행사는 회사 투자자 관계 웹사이트에서 다시보기로 제공됩니다.
Ainos (NASDAQ:AIMD), entreprise spécialisée dans la détection d'odeurs par IA, a annoncé sa participation à un entretien informel avec Water Tower Research le 20 août 2025 à 11h00 ET (heure de l'Est).
Lors de cet entretien, la société présentera sa technologie AI Nose, ses récents partenariats stratégiques et l'avancement des déploiements. La direction évoquera également les opportunités de marché, les jalons prévus pour 2025–2026 et le positionnement d'Ainos comme entreprise technologique essentielle. L'événement sera disponible en replay sur le site relations investisseurs de la société.
Ainos (NASDAQ:AIMD), ein auf KI-basierte Geruchserkennung spezialisiertes Unternehmen, hat seine Teilnahme an einem Fireside-Chat mit Water Tower Research am 20. August 2025 um 11:00 Uhr ET (Eastern Time) angekündigt.
Im Gespräch wird das Unternehmen seine AI Nose-Technologie, jüngste strategische Partnerschaften und den Fortschritt bei den Implementierungen erläutern. Das Management wird außerdem Marktchancen, geplante Meilensteine für 2025–2026 und die Positionierung von Ainos als Kerntechnologieunternehmen thematisieren. Die Veranstaltung wird auf der Investor-Relations-Website des Unternehmens als Replay verfügbar sein.
- None.
- None.
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET.
Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment. In addition, the Company will also share insights into market and scale-up opportunities across multiple sectors, outline key milestones expected for the remainder of 2025 and into 2026, and make the case for why Ainos should be regarded as a technology company at its core.
To register for this listen-only event, please visit:
Fireside Chat Registration Link
The replay of the fireside chat will be available under "Events" on Ainos' investor relations website at https://ir.ainos.com/.
About AI Nose
AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.
About Ainos, Inc.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information:
Feifei Shen
ir@ainos.com
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Ainos (AIMD) scheduled to participate in the Water Tower Research fireside chat?
What topics will be covered in the Ainos (AIMD) fireside chat?
How can investors access the Ainos (AIMD) fireside chat?
What is Ainos (AIMD) main technology focus?
